Lipella Pharmaceuticals Inc(LIPO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LIPO Lipella Pharmaceuticals Inc

交易中 10-06 10:38:28 EDT 延时

{"stockData":{"symbol":"LIPO","market":"US","secType":"STK","nameCN":"Lipella Pharmaceuticals Inc","latestPrice":0.0005,"timestamp":1791297508895,"preClose":0.0005,"halted":0,"volume":20,"delay":15,"changeRate":0,"floatShares":4175899,"shares":4467395,"eps":-2.26,"marketStatus":"交易中","change":0,"latestTime":"10-06 10:38:28 EDT 延时","open":0.0005,"high":0.0005,"low":0.0005,"amount":0.01,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-2.26,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791316800000},"marketStatusCode":2,"adr":0,"listingDate":1750392000000,"exchange":"PINK","adjPreClose":0.0005,"volumeRatio":0.039444},"requestUrl":"/m/hq/s/LIPO/wiki","defaultTab":"wiki","newsList":[{"id":"1136726301","title":"Lipella Pharmaceuticals宣布破产法院于6月4日批准资产出售协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1136726301","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136726301?lang=zh_cn&edition=full","pubTime":"2026-07-16 00:59","pubTimestamp":1784134741,"startTime":"0","endTime":"0","summary":"根据7月15日向美国证券交易委员会提交的文件，Lipella Pharmaceuticals Inc披露，破产法院已于2026年6月4日正式批准了公司的资产出售及相关购买协议。这一关键进展标志着该公司在破产重组进程中迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130679812","title":"Lipella Pharmaceuticals Inc：拟申请常规“首日”救济，若获法院批准将维持日常运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1130679812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130679812?lang=zh_cn&edition=full","pubTime":"2026-03-31 08:23","pubTimestamp":1774916598,"startTime":"0","endTime":"0","summary":"Lipella Pharmaceuticals Inc计划向法院提出常规的“首日”救济申请。此类救济措施若获批准，将使公司能够继续维持正常的日常业务运营。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622684085","title":"隆利科技(300752.SZ)：目前公司的LIPO新型封装技术产品良率已爬升至合理水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2622684085","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622684085?lang=zh_cn&edition=full","pubTime":"2026-03-27 18:07","pubTimestamp":1774606021,"startTime":"0","endTime":"0","summary":"格隆汇3月27日丨隆利科技(300752.SZ)在投资者互动平台表示，目前公司的LIPO新型封装技术产品良率已爬升至合理水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260327/32104877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0214","LIPO","300752","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611323861","title":"隆利科技(300752.SZ)：公司积极推进LIPO新型封装技术进一步升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2611323861","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2611323861?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:47","pubTimestamp":1770972421,"startTime":"0","endTime":"0","summary":"格隆汇2月13日丨隆利科技(300752.SZ)在投资者互动平台表示，公司积极推进LIPO新型封装技术进一步升级，其中3D打印快速成型技术路径仍在研发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260213/32017458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4139","BK0214","LIPO","300752"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518420948","title":"Lipella Pharmaceuticals Inc.盘中异动 股价大跌7.86%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518420948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518420948?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:36","pubTimestamp":1741631812,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时36分，Lipella Pharmaceuticals Inc.股票出现异动，股价快速跳水7.86%。截至发稿，该股报2.11美元/股，成交量5.722万股，换手率4.73%，振幅7.42%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6070.51%、3849.18%、1007.41%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023652abf36c48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023652abf36c48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517945912","title":"Lipella Pharmaceuticals Inc.盘中异动 早盘快速拉升6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517945912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517945912?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:48","pubTimestamp":1741186135,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时48分，Lipella Pharmaceuticals Inc.股票出现异动，股价快速上涨6.42%。截至发稿，该股报2.67美元/股，成交量2741股，换手率0.23%，振幅2.42%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.54%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为565.27%、266.94%、213.78%，振幅较大的相关个股有Nkgen Biotech, Inc.、Silexion Therapeutics Corp、Aditxt, Inc.，振幅分别为40.77%、26.13%、23.90%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224855a260cdb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224855a260cdb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516637340","title":"Lipella Pharmaceuticals Inc.盘中异动 急速下跌5.46%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516637340?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:51","pubTimestamp":1741013512,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时51分，Lipella Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.46%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、木薯科学涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为605.70%、114.49%、86.01%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为145.09%、70.53%、35.60%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032251529637b23b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032251529637b23b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514522385","title":"Lipella Pharmaceuticals Inc.盘中异动 快速跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514522385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514522385?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:41","pubTimestamp":1740667306,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时41分，Lipella Pharmaceuticals Inc.股票出现异动，股价急速下挫5.53%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为452.86%、93.94%、78.79%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Channel Therapeutics Corporation，振幅分别为41.12%、21.99%、16.89%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224146a2567cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224146a2567cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513733507","title":"Lipella Pharmaceuticals Inc.盘中异动 早盘股价大跌5.73%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513733507?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:33","pubTimestamp":1740411187,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时33分，Lipella Pharmaceuticals Inc.股票出现波动，股价急速下跌5.73%。截至发稿，该股报2.96美元/股，成交量3.7893万股，换手率3.13%，振幅8.24%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为206.98%、87.12%、27.91%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233307962ea76b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233307962ea76b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512489577","title":"Lipella Pharmaceuticals Inc.盘中异动 早盘股价大跌5.55%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512489577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512489577?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:46","pubTimestamp":1739979960,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时46分，Lipella Pharmaceuticals Inc.股票出现异动，股价快速下挫5.55%。截至发稿，该股报3.40美元/股，成交量3.7812万股，换手率3.13%，振幅2.92%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Editas Medicine, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为533.62%、238.61%、169.74%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219234600988b3d6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219234600988b3d6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512391198","title":"Lipella Pharmaceuticals Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512391198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512391198?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:36","pubTimestamp":1739900173,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时36分，Lipella Pharmaceuticals Inc.股票出现波动，股价快速跳水5.15%。截至发稿，该股报3.68美元/股，成交量17.1757万股，换手率14.21%，振幅4.63%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为544.47%、190.08%、158.44%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219013613988a1b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219013613988a1b45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511026691","title":"Lipella Pharmaceuticals Inc.盘中异动 股价大跌5.22%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511026691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511026691?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:09","pubTimestamp":1739545771,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时09分，Lipella Pharmaceuticals Inc.股票出现波动，股价快速跳水5.22%。截至发稿，该股报3.81美元/股，成交量6.7529万股，换手率5.59%，振幅7.21%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2278.49%、580.49%、463.58%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502142309319885928b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502142309319885928b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511759525","title":"Lipella Pharmaceuticals Inc.盘中异动 股价大跌6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511759525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511759525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:45","pubTimestamp":1739457909,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时45分，Lipella Pharmaceuticals Inc.股票出现异动，股价快速跳水6.11%。截至发稿，该股报4.22美元/股，成交量7.8234万股，换手率6.47%，振幅4.23%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Enanta Pharmaceuticals, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Moleculin Biotech, Inc.较为活跃，换手率分别为1141.41%、1045.54%、291.35%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Moleculin Biotech, Inc.、Edesa Biotech, Inc.，振幅分别为69.33%、64.29%、56.44%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224509a244ae6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224509a244ae6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2510637938","title":"Lipella Pharmaceuticals Inc.盘中异动 早盘股价大跌6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510637938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510637938?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739198007,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，Lipella Pharmaceuticals Inc.股票出现波动，股价急速跳水6.56%。截至发稿，该股报2.87美元/股，成交量15.195万股，换手率12.57%，振幅1.95%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.、Solid Biosciences Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为909.72%、598.06%、255.77%，振幅较大的相关个股有Tyra Biosciences, Inc.、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为100.83%、26.71%、22.45%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102233289880786e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102233289880786e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509444727","title":"Lipella Pharmaceuticals Inc.盘中异动 急速跳水12.04%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509444727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509444727?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:31","pubTimestamp":1738938719,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时31分，Lipella Pharmaceuticals Inc.股票出现异动，股价大幅下挫12.04%。截至发稿，该股报4.09美元/股，成交量47.5656万股，换手率39.35%，振幅1.72%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Nutriband Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为1055.51%、39.51%、33.37%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nutriband Inc.、Renovorx, Inc.，振幅分别为30.97%、16.46%、10.27%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223159a23d2355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223159a23d2355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509027744","title":"Lipella Pharmaceuticals Inc.股价飙升156.59% 市值涨4.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509027744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509027744?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:30","pubTimestamp":1738852234,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时30分，Lipella Pharmaceuticals Inc.股票出现异动，股价快速上涨156.59%。截至发稿，该股报6.62美元/股，成交量4336.08万股，换手率3586.74%，振幅0.00%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Transcode Therapeutics, Inc.、Relmada Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3586.80%、314.12%、112.96%，振幅较大的相关个股有Valneva Se、Fennec Pharmaceuticals Inc.、Transcode Therapeutics, Inc.，振幅分别为7.95%、4.27%、3.24%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223034961a18f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223034961a18f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508759450","title":"Lipella Pharmaceuticals Inc.盘中异动 快速跳水8.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508759450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508759450?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:53","pubTimestamp":1738680813,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时53分，Lipella Pharmaceuticals Inc.股票出现异动，股价大幅下挫8.42%。截至发稿，该股报2.50美元/股，成交量1833股，换手率0.15%，振幅1.65%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1306.06%、823.13%、199.89%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025、Invivyd, Inc.，振幅分别为49.48%、40.00%、29.25%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225333abc22c77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225333abc22c77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506355813","title":"消息称OPPO Find X8 Ultra手机采用直屏设计、LIPO极窄封装","url":"https://stock-news.laohu8.com/highlight/detail?id=2506355813","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506355813?lang=zh_cn&edition=full","pubTime":"2025-01-26 13:39","pubTimestamp":1737869996,"startTime":"0","endTime":"0","summary":"IT之家 1 月 26 日消息，博主 @数码闲聊站 今日爆料称，OPPO Find X8 Ultra 手机是第一个直屏超大杯，2025 核心产品线全面上直屏，LIPO 极窄封装也会第一波上。该博主此前透露，OPPO 将在 2025 年推出 Find X8 Ultra、Find X8 mini 两款直板机。该博主还称自己已经体验了 OPPO Find X8S，该机将采用天玑 9400 + 处理器。据IT之家此前报道，有爆料称 OPPO Find X8 Ultra 设计依旧定位影像旗舰，后置四摄模组：一英寸索尼 LYT 900 主摄 + 两颗 5000 万像素潜望式长焦 + 索尼 IMX 882 超广角。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8gSN9HwGAag","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK4139","LIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503586628","title":"Lipella Pharmaceuticals Inc.盘中异动 股价大涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503586628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503586628?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:44","pubTimestamp":1736779447,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时44分，Lipella Pharmaceuticals Inc.股票出现波动，股价快速拉升5.86%。截至发稿，该股报3.07美元/股，成交量3.736万股，换手率3.09%，振幅7.93%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4213.92%、2318.34%、402.73%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Kairos Pharma, Ltd.，振幅分别为104.79%、102.87%、67.84%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132244079864d86c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132244079864d86c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502808862","title":"Lipella Pharmaceuticals Inc.盘中异动 早盘大幅下跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502808862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502808862?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519525,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Lipella Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.36%。截至发稿，该股报3.00美元/股，成交量7631股，换手率0.63%，振幅0.00%。Lipella Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为901.72%、131.67%、105.87%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为15.25%、10.00%、8.90%。Lipella Pharmaceuticals Inc.公司简介：Lipella Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223205aba6029d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223205aba6029d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIPO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lipella.com","description":"Lipella Pharmaceuticals Inc.于2005年2月16日在特拉华州注册成立。他们是一家临床阶段的生物技术公司，专注于通过重新配制现有仿制药中的活性剂并针对新应用优化这些重新配制来开发新药。","exchange":"PINK","name":"Lipella Pharmaceuticals Inc","nameEN":"Lipella Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lipella Pharmaceuticals Inc(LIPO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lipella Pharmaceuticals Inc(LIPO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lipella Pharmaceuticals Inc,LIPO,Lipella Pharmaceuticals Inc股票,Lipella Pharmaceuticals Inc股票老虎,Lipella Pharmaceuticals Inc股票老虎国际,Lipella Pharmaceuticals Inc行情,Lipella Pharmaceuticals Inc股票行情,Lipella Pharmaceuticals Inc股价,Lipella Pharmaceuticals Inc股市,Lipella Pharmaceuticals Inc股票价格,Lipella Pharmaceuticals Inc股票交易,Lipella Pharmaceuticals Inc股票购买,Lipella Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lipella Pharmaceuticals Inc(LIPO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lipella Pharmaceuticals Inc(LIPO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}